AR018349A1 - PHARMACEUTICAL COMPOSITION THAT INCLUDES STROGENS AND ANTIESTROGENS AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT - Google Patents
PHARMACEUTICAL COMPOSITION THAT INCLUDES STROGENS AND ANTIESTROGENS AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCTInfo
- Publication number
- AR018349A1 AR018349A1 ARP990102226A AR018349A1 AR 018349 A1 AR018349 A1 AR 018349A1 AR P990102226 A ARP990102226 A AR P990102226A AR 018349 A1 AR018349 A1 AR 018349A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- group
- unsaturated
- optionally substituted
- independently selected
- Prior art date
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Composicion farmacéutica que comprende uno o más estrogenos y un compuesto que es util como agente estrogénico selectivo de tejidos, que tiene laestructura general de formulas I y II en donde R1 se selecciona entre H, OH o los alquil éteres o ésteresC1-4 de los mismos, o halogenos; R2,R3, R4 R5 y R6 son independientemente seleccionados entre H, OH o los alquil éteres o ésteres C1-4 de los mismos, halogeno, ciano, alquilo C1-6, otrifluorometilo, con la condicion que, cuando R1 es H, R2 no es OH;X es (CH2)n, n es 1 o 2, n es 2-4; Y se selecciona entre: a) la porcion, de la formulaIII en donde R7 y R8 son independientemente seleccionados entre el grupo de H, alquilo C1-6, fenilo; b) un heterociclo de cinco miembros, saturado, insaturadoo parcialmente insaturado, que contiene hasta dos heteroátomos seleccionados entre el grupo que consiste de -O-, -NH-, -N(alquilo C1-4)-, -N=, y -S(O)m-, endonde m es un entero de desde 0 - 2, opcionalmente sustituido con 1 - 3 sustituyentes independientemente seleccionados entre el grupo que consiste de hidrogeno,hidroxilo, halo, alquilo C1-4, trihalometilo, alcoxi C1-4, trihalometoxi, aciloxi C1-4, alquiltio C1-4, alquilsulfinilo C1-4, alquilsulfonilo C1-4, hidroxialquilo (C1-4), fenilo opcionalmente sustituido con 1 -3 alquilo(C1-4), -CO2H-, CN-, CONHR1-, -NH2-, alquilamino C1-4, dialquilamino C1-4, -NHSO2R1-, -NHCOR1-,-NO2-; c) un heterociclo de seis miembros, saturado, insaturado o parcialmente insaturado, que contiene hasta dos heteroátomos seleccionados entre el grupo queconsiste de -O-, -NH-, -N(alquilo C1-4)-, -N=, y -S(O)m-, en donde m es un entero de desde 0 - 2, opcionalmente sustituido con 1 -3 sustituyentesindependientemente seleccionados entre el grupo que consiste en hidrogeno, hidroxilo, halo, alquilo C1-4, trihalometilo, alcoxi C1-4, trihalometoxi, aciloxiC1-4, alquiltio C1-4, alquilsulfinilo C1-4, alquilsulfonilo C1-4, hidroxi alquilo(C1-4), fenilo opcionalmente sustituido con 1 - 3 alquilo (C1-4), -CO2H-, -CN--CONHR1-, -NH2, alquilamino C1-4 dialquilamino C1-4, -NHSO2R1-, NHCOR1-, -NO2-, d) un heterociclo de siete miembros, saturado, insaturado, o parcialmentePharmaceutical composition comprising one or more estrogens and a compound that is useful as a selective estrogenic agent of tissues, having the general structure of formulas I and II wherein R 1 is selected from H, OH or the alkyl ethers or C 1-4 esters thereof , or halogens; R2, R3, R4 R5 and R6 are independently selected from H, OH or C1-4 alkyl ethers or esters thereof, halogen, cyano, C1-6 alkyl, otrifluoromethyl, with the proviso that, when R1 is H, R2 it is not OH; X is (CH2) n, n is 1 or 2, n is 2-4; And it is selected from: a) the portion, of the formula III where R7 and R8 are independently selected from the group of H, C1-6 alkyl, phenyl; b) a five-membered, saturated, unsaturated or partially unsaturated heterocycle, containing up to two heteroatoms selected from the group consisting of -O-, -NH-, -N (C1-4 alkyl) -, -N =, and - S (O) m-, where m is an integer from 0-2, optionally substituted with 1-3 substituents independently selected from the group consisting of hydrogen, hydroxyl, halo, C1-4 alkyl, trihalomethyl, C1-4 alkoxy , trihalomethoxy, C1-4 acyloxy, C1-4 alkylthio, C1-4 alkylsulfinyl, C1-4 alkylsulfonyl, hydroxy (C1-4) alkyl, phenyl optionally substituted with 1-3 alkyl (C1-4), -CO2H-, CN- , CONHR1-, -NH2-, C1-4 alkylamino, C1-4 dialkylamino, -NHSO2R1-, -NHCOR1 -, - NO2-; c) a six-membered heterocycle, saturated, unsaturated or partially unsaturated, containing up to two heteroatoms selected from the group consisting of -O-, -NH-, -N (C1-4 alkyl) -, -N =, and - S (O) m-, wherein m is an integer from 0-2, optionally substituted with 1-3 substituents independently selected from the group consisting of hydrogen, hydroxyl, halo, C1-4 alkyl, trihalomethyl, C1-4 alkoxy , trihalomethoxy, C1-4 acyloxy, C1-4 alkylthio, C1-4 alkylsulfinyl, C1-4 alkylsulfonyl, hydroxy (C1-4) alkyl, phenyl optionally substituted with 1-3 (C1-4) alkyl, -CO2H-, -CN --CONHR1-, -NH2, C1-4 alkylamino C1-4 dialkylamino, -NHSO2R1-, NHCOR1-, -NO2-, d) a seven-membered heterocycle, saturated, unsaturated, or partially
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7671198A | 1998-05-12 | 1998-05-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR018349A1 true AR018349A1 (en) | 2001-11-14 |
Family
ID=45606461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990102226 AR018349A1 (en) | 1998-05-12 | 1999-05-11 | PHARMACEUTICAL COMPOSITION THAT INCLUDES STROGENS AND ANTIESTROGENS AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR018349A1 (en) |
-
1999
- 1999-05-11 AR ARP990102226 patent/AR018349A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR006705A1 (en) | COMPOUNDS OF 3- [4- (2-PHENYL-INDOL-1-ILMETIL) -PHENYL] -ACRYLAMIDE AND 2-PHENYL-1- [4- (AMINO-1-IL-ALQU-1-INIL) -BENCIL] - 1H-INDOL-5-OL, METHOD FOR PREPARING MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR020074A1 (en) | PHARMACEUTICAL COMPOSITION OF 2-PHENYL-1- [4- (2-AMINOETOXI) BENCIL] -INDOL AND ESTROGEN, AND, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
CO4900051A1 (en) | STROGENIC AGENTS | |
AR023727A1 (en) | COMPOUNDS USED IN THE TREATMENT OF INFLAMMATORY MATTERS | |
AR015183A1 (en) | ARILOXI-ALQUIL-DIALQUILAMINAS AND PROCESSES FOR YOUR PRODUCTION | |
ES2142798T3 (en) | DERIVATIVES OF 3-AMIDO PIRAZOL, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
FI971018A (en) | Pharmaceutical compounds | |
AR022230A1 (en) | TRIAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND USE OF THE SAME TO PREPARE SUCH COMPOSITION | |
AR031930A1 (en) | MCH ANTAGONISTS AND ITS USE IN THE TREATMENT OF OBESITY | |
ES2123654T3 (en) | CARBAPENEMS CONTAINING A PHENYL GROUP SUBSTITUTED WITH CARBOXI, PROCESSES FOR ITS PREPARATION, INTERMEDIATE PRODUCTS AND USE AS ANTIBIOTICS. | |
ES2052881T3 (en) | BLOOD PRESSURE REDUCING AGENTS. | |
AR007530A1 (en) | GEL FOR THE TRANSDERMIC ADMINISTRATION | |
AR030064A1 (en) | METHODS TO INHIBIT THE UTEROTROPHIC EFFECTS OF ESTROGEN AGENTS | |
AR018330A1 (en) | PHARMACEUTICAL COMPOSITIONS THAT INCLUDE MACROLIDES AS ACTIVE AGENTS FOR THE THERAPY AND PROPHYLAXIS OF SKIN DISEASES | |
DK81885D0 (en) | PYRIDO-BENZOTHIAZINE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING AT LEAST ONE SUCH DERIVATIVE | |
ES2194535T3 (en) | 4-TRIFLUOROMETIL-3-OXAZOLILPIRIDINAS, PROCEDURE FOR THEIR PREPARATION, AGENTS THAT CONTAIN THEM AND ITS USE AS AN AGENT PARALLY FIGHT AGAINST HARMFUL ORGANISMS. | |
ES2090083T3 (en) | CEPHALOSPORIN DERIVATIVES, PROCEDURE FOR THE PREPARATION AND ANTIMICROBIAL COMPOSITION CONTAINING THESE DERIVATIVES. | |
KR950011445A (en) | Galantamine derivatives, preparation method thereof and use thereof as medicament | |
AR034392A1 (en) | COMPOUNDS DERIVED FROM 3, 16-DIHIDROXI-ESTRA-1,3,5 (10) -TRIENO, EMPLOYMENT OF THE SAME AND STRUCTURAL PARTS OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
ES2161201T1 (en) | DERIVATIVE OF BENZAMIDA, COMPOSITIONS CONTAINING SUCH DERIVATIVE AND ITS EMPLOYMENT. | |
AR032066A1 (en) | AGENT FOR THERAPEUTIC AND PROFILACTIC TREATMENT OF NEUROPATHIC PAIN | |
KR950703941A (en) | Nitrogen monoxide synthase inhibitor (NITROGEN MONOXIDE SYNTHESIS INHIBITOR) | |
AR018349A1 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES STROGENS AND ANTIESTROGENS AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
CO5221087A1 (en) | PESTICIDES / DEPSIPEPTIDES | |
BR0114216A (en) | Spray Drying Catalyst Compositions and Spray Drying Methods |